{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:07:40Z","timestamp":1784408860401,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,20]]},"DOI":"10.7759\/cureus.84474","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:42:32Z","timestamp":1747752152000},"source":"Crossref","is-referenced-by-count":1,"title":["Sertraline-Induced Bradycardia: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Narges","family":"Joshaghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaskaran","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravleen K","family":"Suri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Udegbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajiya","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khai","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasidhar","family":"Gunturu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ramb.2012.12.006","article-title":"Cardiovascular risk in individuals with depression","volume":"59","author":"Bivanco-Lima D","year":"2013","unstructured":"Bivanco-Lima D, Souza Santos Id, Vannucchi AM, Almeida Ribeiro MC. Cardiovascular risk in individuals with depression. Rev Assoc Med Bras (1992). 2013, 59:298-304. 10.1016\/j.ramb.2012.12.006","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-3999(99)00086-0","article-title":"Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing","volume":"48","author":"Herrmann C","year":"2000","unstructured":"Herrmann C, Brand-Driehorst S, Buss U, R\u00fcger U. Effects of anxiety and depression on 5-year mortality in 5,057 patients referred for exercise testing. J Psychosom Res. 2000, 48:455-62. 10.1016\/s0022-3999(99)00086-0","journal-title":"J Psychosom Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2009.81","article-title":"National patterns in antidepressant medication treatment","volume":"66","author":"Olfson M","year":"2009","unstructured":"Olfson M, Marcus SC. National patterns in antidepressant medication treatment. Arch Gen Psychiatry. 2009, 66:848-56. 10.1001\/archgenpsychiatry.2009.81","journal-title":"Arch Gen Psychiatry"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015786","article-title":"Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: a network meta-analysis of randomized controlled trials","volume":"98","author":"Guo S","year":"2019","unstructured":"Guo S, Chen L, Cheng S, Xu H. Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: a network meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019, 98:e15786. 10.1097\/MD.0000000000015786","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3724\/SP.J.1263.2011.00243","article-title":"Cardiologic side effects of psychotropic drugs","volume":"8","author":"Marano G","year":"2011","unstructured":"Marano G, Traversi G, Romagnoli E, et al.. Cardiologic side effects of psychotropic drugs. J Geriatr Cardiol. 2011, 8:243-53. 10.3724\/SP.J.1263.2011.00243","journal-title":"J Geriatr Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/bdrb.21003","article-title":"Antidepressants cause bradycardia and heart block in GD 13 rat embryos in vitro","volume":"95","author":"Ababneh D","year":"2012","unstructured":"Ababneh D, Ritchie H, Webster WS. Antidepressants cause bradycardia and heart block in GD 13 rat embryos in vitro. Birth Defects Res B Dev Reprod Toxicol. 2012, 95:184-93. 10.1002\/bdrb.21003","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.2.181","article-title":"Sudden cardiac death secondary to antidepressant and antipsychotic drugs","volume":"7","author":"Sicouri S","year":"2008","unstructured":"Sicouri S, Antzelevitch C. Sudden cardiac death secondary to antidepressant and antipsychotic drugs. Expert Opin Drug Saf. 2008, 7:181-94. 10.1517\/14740338.7.2.181","journal-title":"Expert Opin Drug Saf"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.10.4.463","article-title":"Bradycardia caused by interaction of venlafaxine and cyclosporine: a case report","volume":"10","author":"Azizi M","year":"2019","unstructured":"Azizi M, Elyasi F, Niksolat Roodposhti F. Bradycardia caused by interaction of venlafaxine and cyclosporine: a case report. Caspian J Intern Med. 2019, 10:463-7. 10.22088\/cjim.10.4.463","journal-title":"Caspian J Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000097011","article-title":"Severe bradycardia in a stroke patient caused by a single low dose of escitalopram","volume":"57","author":"Beyenburg S","year":"2007","unstructured":"Beyenburg S, Sch\u00f6negger K. Severe bradycardia in a stroke patient caused by a single low dose of escitalopram. Eur Neurol. 2007, 57:50-1. 10.1159\/000097011","journal-title":"Eur Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.1.119.55630","article-title":"Reversal of citalopram-induced junctional bradycardia with intravenous sodium bicarbonate","volume":"25","author":"Brucculeri M","year":"2005","unstructured":"Brucculeri M, Kaplan J, Lande L. Reversal of citalopram-induced junctional bradycardia with intravenous sodium bicarbonate. Pharmacotherapy. 2005, 25:119-22. 10.1592\/phco.25.1.119.55630","journal-title":"Pharmacotherapy"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1998.0419","article-title":"Bradycardia during citalopram treatment: a case report","volume":"39","author":"Favre MP","year":"1999","unstructured":"Favre MP, Sztajzel J, Bertschy G. Bradycardia during citalopram treatment: a case report. Pharmacol Res. 1999, 39:149-50. 10.1006\/phrs.1998.0419","journal-title":"Pharmacol Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02546.x","article-title":"Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses","volume":"61","author":"Friberg LE","year":"2006","unstructured":"Friberg LE, Isbister GK, Duffull SB. Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses. Br J Clin Pharmacol. 2006, 61:177-90. 10.1111\/j.1365-2125.2005.02546.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1002\/hup.470100212","article-title":"Severe bradycardia following fluoxetine administration: a case report in a young HIV-1 infected woman","volume":"10","author":"Grassi B","year":"1995","unstructured":"Grassi B, Gambini O, Scarone S. Severe bradycardia following fluoxetine administration: a case report in a young HIV-1 infected woman. Hum Psychopharmacol Clin Exp. 1995, 10:153-5.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5350\/DAJPN2018310309","article-title":"Therapeutic single-dose mirtazapine-induced symptomatic bradycardia: a case report","volume":"31","author":"Gundogmus PD","year":"2018","unstructured":"Gundogmus PD, Gundogmus I, Olcu EB, Karagoz A, Algul A. Therapeutic single-dose mirtazapine-induced symptomatic bradycardia: a case report. Dusunen Adam. 2018, 31:304-7. 10.5350\/DAJPN2018310309","journal-title":"Dusunen Adam"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1081\/clt-120037428","article-title":"Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose","volume":"42","author":"Isbister GK","year":"2004","unstructured":"Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004, 42:277-85. 10.1081\/clt-120037428","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1248578","article-title":"QTc prolongation during treatment with agomelatine (Article in German)","volume":"37","author":"Kozian R","year":"2010","unstructured":"Kozian R, Syrbe G. QTc prolongation during treatment with agomelatine (Article in German). Psychiatr Prax. 2010, 37:405-7. 10.1055\/s-0030-1248578","journal-title":"Psychiatr Prax"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1133662","article-title":"Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature","volume":"10","author":"Li LC","year":"2023","unstructured":"Li LC, Sun W, Lv XQ, Xu YY, Hu Y, Shi JN. Escitalopram-induced sinus bradycardia in coronary heart disease combined with depression: a case report and review of literature. Front Cardiovasc Med. 2023, 10:1133662. 10.3389\/fcvm.2023.1133662","journal-title":"Front Cardiovasc Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5455\/bcp.20140304090654","article-title":"Escitalopram-induced bradycardia in elderly individuals: a case series report","volume":"25","author":"Ozdilek B","year":"2015","unstructured":"Ozdilek B. Escitalopram-induced bradycardia in elderly individuals: a case series report. Klinik Psikofarmakol Bu\u0308lteni. 2015, 25:183-5. 10.5455\/bcp.20140304090654","journal-title":"Klinik Psikofarmakol Bu\u0308lteni"},{"key":"ref19","article-title":"Dose-dependent bradycardia with citalopram in an elderly patient","volume":"12","author":"Padala KP","year":"2010","unstructured":"Padala KP, Padala PR, Wengel SP. Dose-dependent bradycardia with citalopram in an elderly patient. Prim Care Companion J Clin Psychiatry. 2010, 12:e1-2.","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref20","article-title":"Metoprolol and sertraline combined treatment may increase the risk of bradycardia","volume":"37","author":"Protopapas A","year":"2020","unstructured":"Protopapas A, Lambrinou E. Metoprolol and sertraline combined treatment may increase the risk of bradycardia. Arch Hell Med. 2020, 37:692-5.","journal-title":"Arch Hell Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-11225","article-title":"Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker","volume":"33","author":"Rothenh\u00e4usler HB","year":"2000","unstructured":"Rothenh\u00e4usler HB, Hoberl C, Ehrentrout S, Kapfhammer HP, Weber MM. Suicide attempt by pure citalopram overdose causing long-lasting severe sinus bradycardia, hypotension and syncopes: successful therapy with a temporary pacemaker. Pharmacopsychiatry. 2000, 33:150-2. 10.1055\/s-2000-11225","journal-title":"Pharmacopsychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.12740\/PP\/OnlineFirst\/96286","article-title":"Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders","volume":"53","author":"Woro\u0144 J","year":"2019","unstructured":"Woro\u0144 J, Siwek M, Gorostowicz A. Adverse effects of interactions between antidepressants and medications used in treatment of cardiovascular disorders. Psychiatr Pol. 2019, 53:977-95. 10.12740\/PP\/OnlineFirst\/96286","journal-title":"Psychiatr Pol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014524","article-title":"TCA poisoning treated in the intensive care unit","volume":"23","author":"Hult\u00e9n BA","year":"1990","unstructured":"Hult\u00e9n BA. TCA poisoning treated in the intensive care unit. Pharmacopsychiatry. 1990, 23:14-6. 10.1055\/s-2007-1014524","journal-title":"Pharmacopsychiatry"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/1753944708096282","article-title":"Electrophysiological changes of cardiac function during antidepressant treatment","volume":"3","author":"Sala M","year":"2009","unstructured":"Sala M, Lazzaretti M, De Vidovich G, Caverzasi E, Barale F, d'Allio G, Brambilla P. Electrophysiological changes of cardiac function during antidepressant treatment. Ther Adv Cardiovasc Dis. 2009, 3:29-43. 10.1177\/1753944708096282","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.2174\/1381612043383872","article-title":"Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?","volume":"10","author":"Pacher P","year":"2004","unstructured":"Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?. Curr Pharm Des. 2004, 10:2463-75. 10.2174\/1381612043383872","journal-title":"Curr Pharm Des"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(08)70643-3","article-title":"Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines","volume":"24","author":"Baranchuk A","year":"2008","unstructured":"Baranchuk A, Simpson CS, Methot M, Gibson K, Strum D. Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Can J Cardiol. 2008, 24:e38-40. 10.1016\/s0828-282x(08)70643-3","journal-title":"Can J Cardiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1177\/0960327107078666","article-title":"Escitalopram ingestions reported to Texas poison control centers, 2002-2005","volume":"26","author":"Forrester MB","year":"2007","unstructured":"Forrester MB. Escitalopram ingestions reported to Texas poison control centers, 2002-2005. Hum Exp Toxicol. 2007, 26:473-82. 10.1177\/0960327107078666","journal-title":"Hum Exp Toxicol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1017\/s1092852900021027","article-title":"Serotonin syndrome associated with the use of escitalopram","volume":"12","author":"Huska MT","year":"2007","unstructured":"Huska MT, Catalano G, Catalano MC. Serotonin syndrome associated with the use of escitalopram. CNS Spectr. 2007, 12:270-4. 10.1017\/s1092852900021027","journal-title":"CNS Spectr"},{"key":"ref29","article-title":"Severe serotonin syndrome from escitalopram overdose","volume":"42","author":"Olsen D","year":"2004","unstructured":"Olsen D, Dart R, Robinett M. Severe serotonin syndrome from escitalopram overdose. J Toxicol Clin Toxicol. 2004, 42:744-5.","journal-title":"J Toxicol Clin Toxicol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/BF00464566","article-title":"Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study","volume":"77","author":"Pedersen OL","year":"1982","unstructured":"Pedersen OL, Kragh-S\u00f8rensen P, Bjerre M, Over\u00f8 KF, Gram LF. Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study. Psychopharmacology (Berl). 1982, 77:199-204. 10.1007\/BF00464566","journal-title":"Psychopharmacology (Berl)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199910000-00004","article-title":"Cardiac safety of citalopram: prospective trials and retrospective analyses","volume":"19","author":"Rasmussen SL","year":"1999","unstructured":"Rasmussen SL, Over\u00f8 KF, Tangh\u00f8j P. Cardiac safety of citalopram: prospective trials and retrospective analyses. J Clin Psychopharmacol. 1999, 19:407-15. 10.1097\/00004714-199910000-00004","journal-title":"J Clin Psychopharmacol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2007.0147","article-title":"Prolonged QTc interval in a 14-year-old girl with escitalopram overdose","volume":"18","author":"Scharko AM","year":"2008","unstructured":"Scharko AM, Schumacher J. Prolonged QTc interval in a 14-year-old girl with escitalopram overdose. J Child Adolesc Psychopharmacol. 2008, 18:297-8. 10.1089\/cap.2007.0147","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2009.04.016","article-title":"Clinical and ECG effects of escitalopram overdose","volume":"54","author":"van Gorp F","year":"2009","unstructured":"van Gorp F, Whyte IM, Isbister GK. Clinical and ECG effects of escitalopram overdose. Ann Emerg Med. 2009, 54:404-8. 10.1016\/j.annemergmed.2009.04.016","journal-title":"Ann Emerg Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2004.06.034","article-title":"Escitalopram intoxication","volume":"20","author":"Yuksel FV","year":"2005","unstructured":"Yuksel FV, Tuzer V, Goka E. Escitalopram intoxication. Eur Psychiatry. 2005, 20:82. 10.1016\/j.eurpsy.2004.06.034","journal-title":"Eur Psychiatry"},{"key":"ref35","article-title":"Selective Serotonin Reuptake Inhibitors","author":"Chu A","year":"2025","unstructured":"Chu A, Wadhwa R. Selective Serotonin Reuptake Inhibitors. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.3109\/08039489309104126","article-title":"The importance of ECG monitoring in antidepressant treatment","volume":"47","author":"Enemark B","year":"1993","unstructured":"Enemark B. The importance of ECG monitoring in antidepressant treatment. Nord J Psychiatry. 1993, 47:57-65.","journal-title":"Nord J Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2005.10101.x","article-title":"Heart rate variability: measurement and clinical utility","volume":"10","author":"Kleiger RE","year":"2005","unstructured":"Kleiger RE, Stein PK, Bigger JT Jr. Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005, 10:88-101. 10.1111\/j.1542-474X.2005.10101.x","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920030-00007","article-title":"Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system","volume":"20","author":"Spigset O","year":"1999","unstructured":"Spigset O. Adverse reactions of selective serotonin reuptake inhibitors: reports from a spontaneous reporting system. Drug Saf. 1999, 20:277-87. 10.2165\/00002018-199920030-00007","journal-title":"Drug Saf"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.930216","article-title":"Citalopram inhibits L-type calcium channel current in rat cardiomyocytes in culture","volume":"51","author":"Hamplov\u00e1-Peichlov\u00e1 J","year":"2002","unstructured":"Hamplov\u00e1-Peichlov\u00e1 J, Kr\u016fsek J, Paclt I, Slav\u00edcek J, Lis\u00e1 V, Vyskocil F. Citalopram inhibits L-type calcium channel current in rat cardiomyocytes in culture. Physiol Res. 2002, 51:317-21. 10.33549\/physiolres.930216","journal-title":"Physiol Res"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.2174\/0929867306666220330184544","article-title":"Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?","volume":"6","author":"Pacher P","year":"1999","unstructured":"Pacher P, Ungvari Z, Nanasi PP, Furst S, Kecskemeti V. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?. Curr Med Chem. 1999, 6:469-80.","journal-title":"Curr Med Chem"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1A136","article-title":"Citalopram-induced bradycardia and presyncope","volume":"35","author":"Isbister GK","year":"2001","unstructured":"Isbister GK, Prior FH, Foy A. Citalopram-induced bradycardia and presyncope. Ann Pharmacother. 2001, 35:1552-5. 10.1345\/aph.1A136","journal-title":"Ann Pharmacother"},{"key":"ref42","article-title":"A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach","volume":"43","author":"Thomas KL","year":"2010","unstructured":"Thomas KL, Ellingrod VL, Bishop JR, Keiser MJ. A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach. Psychopharmacol Bull. 2010, 43:11-22.","journal-title":"Psychopharmacol Bull"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.607446","article-title":"L-T4 therapy in the presence of pharmacological interferents","volume":"11","author":"Benvenga S","year":"2020","unstructured":"Benvenga S. L-T4 therapy in the presence of pharmacological interferents. Front Endocrinol (Lausanne). 2020, 11:607446. 10.3389\/fendo.2020.607446","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.01.003","article-title":"Reversible escitalopram-induced hypothyroidism","volume":"32","author":"Eker SS","year":"2010","unstructured":"Eker SS, Akkaya C, Ersoy C, Sarandol A, Kirli S. Reversible escitalopram-induced hypothyroidism. Gen Hosp Psychiatry. 2010, 32:559.e5-7. 10.1016\/j.genhosppsych.2010.01.003","journal-title":"Gen Hosp Psychiatry"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/1054-139x(94)00069-q","article-title":"Effects of long term treatment with sertraline (Zoloft) simulating hypothyroidism in an adolescent","volume":"16","author":"Harel Z","year":"1995","unstructured":"Harel Z, Biro FM, Tedford WL. Effects of long term treatment with sertraline (Zoloft) simulating hypothyroidism in an adolescent. J Adolesc Health Off Publ Soc Adolesc Med. 1995, 16:232-4. 10.1016\/1054-139x(94)00069-q","journal-title":"J Adolesc Health Off Publ Soc Adolesc Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32331","article-title":"Statins and antidepressants: a comprehensive review and clinical outlook of the risks and benefits of co-prescription (2022)","volume":"14","author":"Gutlapalli SD","year":"2022","unstructured":"Gutlapalli SD, Chaudhuri D, Khan KI, et al.. Statins and antidepressants: a comprehensive review and clinical outlook of the risks and benefits of co-prescription (2022). Cureus. 2022, 14:e32331. 10.7759\/cureus.32331","journal-title":"Cureus"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003093421006","article-title":"The evaluation and management of bradycardia","volume":"342","author":"Mangrum JM","year":"2000","unstructured":"Mangrum JM, DiMarco JP. The evaluation and management of bradycardia. N Engl J Med. 2000, 342:703-9. 10.1056\/NEJM200003093421006","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1177\/106002809202600909","article-title":"Case report of a syncopal episode associated with fluoxetine","volume":"26","author":"McAnally LE","year":"1992","unstructured":"McAnally LE, Threlkeld KR, Dreyling CA. Case report of a syncopal episode associated with fluoxetine. Ann Pharmacother. 1992, 26:1090-1. 10.1177\/106002809202600909","journal-title":"Ann Pharmacother"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2022-0431","article-title":"Drug-induced bradycardia","volume":"23","author":"GN D","year":"2023","unstructured":"GN D, Patil M, Shafiq S. Drug-induced bradycardia. Clin Med (Lond). 2023, 23:173-4. 10.7861\/clinmed.2022-0431","journal-title":"Clin Med (Lond)"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.12788\/jfp.0170","article-title":"23-year-old woman \u2022 syncopal episode \u2022 sinus bradycardia \u2022 history of bipolar disorder \u2022 Dx?","volume":"70","author":"Fletke K","year":"2021","unstructured":"Fletke K, Blanchard J, Kuo S. 23-year-old woman \u2022 syncopal episode \u2022 sinus bradycardia \u2022 history of bipolar disorder \u2022 Dx?. J Fam Pract. 2021, 70:150-1. 10.12788\/jfp.0170","journal-title":"J Fam Pract"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.4070\/kcj.2009.39.9.367","article-title":"Prognosis and natural history of drug-related bradycardia","volume":"39","author":"Lee JH","year":"2009","unstructured":"Lee JH, Ryu HM, Bae MH, et al.. Prognosis and natural history of drug-related bradycardia. Korean Circ J. 2009, 39:367-71. 10.4070\/kcj.2009.39.9.367","journal-title":"Korean Circ J"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-023-01294-8","article-title":"Escitalopram and sertraline population pharmacokinetic analysis in pediatric patients","volume":"62","author":"Poweleit EA","year":"2023","unstructured":"Poweleit EA, Taylor ZL, Mizuno T, Vaughn SE, Desta Z, Strawn JR, Ramsey LB. Escitalopram and sertraline population pharmacokinetic analysis in pediatric patients. Clin Pharmacokinet. 2023, 62:1621-37. 10.1007\/s40262-023-01294-8","journal-title":"Clin Pharmacokinet"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e25231","article-title":"Population pharmacokinetic approach to guide personalized sertraline treatment in Chinese patients","volume":"10","author":"Zhang Z","year":"2024","unstructured":"Zhang Z, Guo Z, Tan Y, et al.. Population pharmacokinetic approach to guide personalized sertraline treatment in Chinese patients. Heliyon. 2024, 10:e25231. 10.1016\/j.heliyon.2024.e25231","journal-title":"Heliyon"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009337946","article-title":"Effect of age, weight, and CYP2C19 genotype on escitalopram exposure","volume":"50","author":"Jin Y","year":"2010","unstructured":"Jin Y, Pollock BG, Frank E, et al.. Effect of age, weight, and CYP2C19 genotype on escitalopram exposure. J Clin Pharmacol. 2010, 50:62-72. 10.1177\/0091270009337946","journal-title":"J Clin Pharmacol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1055\/a-0982-5043","article-title":"Does everything get slower with age? Pharmacokinetics in the elderly","volume":"69","author":"H\u00f6chel J","year":"2019","unstructured":"H\u00f6chel J. Does everything get slower with age? Pharmacokinetics in the elderly. Drug Res (Stuttg). 2019, 69:S7-8. 10.1055\/a-0982-5043","journal-title":"Drug Res (Stuttg)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/359930-sertraline-induced-bradycardia-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T14:42:37Z","timestamp":1747752157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/359930-sertraline-induced-bradycardia-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.84474","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,20]]}}}